Last reviewed · How we verify
Psychiatric treatment with escitalopram — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Psychiatric treatment with escitalopram (Psychiatric treatment with escitalopram) — Klinički Bolnički Centar Zagreb.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Psychiatric treatment with escitalopram TARGET | Psychiatric treatment with escitalopram | Klinički Bolnički Centar Zagreb | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Psychiatric treatment with escitalopram CI watch — RSS
- Psychiatric treatment with escitalopram CI watch — Atom
- Psychiatric treatment with escitalopram CI watch — JSON
- Psychiatric treatment with escitalopram alone — RSS
Cite this brief
Drug Landscape (2026). Psychiatric treatment with escitalopram — Competitive Intelligence Brief. https://druglandscape.com/ci/psychiatric-treatment-with-escitalopram. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab